17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Atrial fibrillation (AF) is associated with high morbidity and mortality, even despite the use of oral anticoagulation (OAC). Soluble suppression of tumorigenicity-2 (sST2) is a member of the interleukin-1 receptor family [interleukin-1 receptor-like 1 (IL1RL1)], which has been associated with an increased risk of mortality and morbidity in heart failure or acute coronary syndrome. We assessed the predictive value of sST2 levels in an unselected 'real-world' cohort of anticoagulated AF patients.

          Related collections

          Author and article information

          Journal
          Eur. J. Clin. Invest.
          European journal of clinical investigation
          Wiley-Blackwell
          1365-2362
          0014-2972
          Sep 2015
          : 45
          : 9
          Affiliations
          [1 ] Departments of Cardiology and Clinical Analysis, Clinic University Hospital Virgen de la Arrixaca, IMIB-Arrixaca, Murcia, Spain.
          [2 ] Department of Biochemistry and Molecular Biology, Universitat Autònoma, Barcelona, Spain.
          [3 ] Red de Investigación Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.
          [4 ] IIB-Sant Pau Biomedical Research Institute, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
          [5 ] Department of Cardiology of Clinic University Hospital Virgen de la Arrixaca, IMIB-Arrixaca, Murcia, Spain.
          [6 ] Hematology and Medical Oncology Unit, General University Hospital Morales Meseguer, Murcia, Spain.
          [7 ] Department of Clinical Analysis, Clinic University Hospital Virgen de la Arrixaca, IMIB-Arrixaca, Murcia, Spain.
          [8 ] Centre for Cardiovascular Sciences, University of Birmingham, City Hospital, Birmingham, UK.
          [9 ] Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
          Article
          10.1111/eci.12482
          26081996
          8682bd36-c2ed-4324-b604-59b82c393bf8
          History

          Soluble suppression of tumorigenicity-2,atrial fibrillation,biomarker,mortality

          Comments

          Comment on this article